Carregant...
Cyclophosphamide for Systemic Sclerosis-Related Interstitial Lung Disease: A Comparison of Scleroderma Lung Studies I and II
OBJECTIVES: To compare safety and efficacy outcomes between the cyclophosphamide (CYC) arms of Scleroderma Lung Study (SLS) I and II. METHODS: Participants enrolled in the CYC arms of SLS I (N=79) and II (N=73) were included. SLS I and II randomized participants to oral CYC for 1 year and followed p...
Guardat en:
| Publicat a: | J Rheumatol |
|---|---|
| Autors principals: | , , , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6697251/ https://ncbi.nlm.nih.gov/pubmed/30770517 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3899/jrheum.180441 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|